Publicacións en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (22)

2024

  1. Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133

  2. Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence

    Nutrients, Vol. 16, Núm. 5

2023

  1. A crowdsourcing database for the copy-number variation of the Spanish population

    Human Genomics, Vol. 17, Núm. 1

  2. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

2022

  1. The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

    Journal of Clinical Virology, Vol. 153

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. CSVS, a crowdsourcing database of the Spanish population genetic variability

    Nucleic acids research, Vol. 49, Núm. D1, pp. D1130-D1137

  3. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

  4. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

    Research and Practice in Thrombosis and Haemostasis, Vol. 5, Núm. 1, pp. 168-178

  5. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Sample pooling for SARS-CoV-2 RT-PCR screening

    Clinical Microbiology and Infection, Vol. 26, Núm. 12, pp. 1687.e1-1687.e5

2019

  1. Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 3, pp. 160-166

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: A case report

    Journal of Antimicrobial Chemotherapy

2017

  1. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595

2016

  1. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100

2014

  1. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 7, pp. 447-458

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85